Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Traumatic Brain Injury Pipeline Highlights - 2017 Update - Research and Markets

Research and Markets
Posted on: 27 Nov 17

The "Traumatic Brain Injury Pipeline Highlights - 2017 Update" drug pipelines has been added to Research and Markets' offering.

Traumatic Brain Injury Pipeline Highlights - 2017 Update, provides most up-to-date information on key pipeline products in the global Traumatic Brain Injury market. It covers emerging therapies for Traumatic Brain Injury in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Traumatic Brain Injury pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Traumatic Brain Injury pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Traumatic Brain Injury pipeline products by the company.

Short-term Launch Highlights:

Find out which Traumatic Brain Injury pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Traumatic Brain Injury Pipeline by Stages

2. Traumatic Brain Injury Pipeline by Drug Class

3. Traumatic Brain Injury Pipeline by Company

4. Traumatic Brain Injury Phase 3 Clinical Trial Insights

5. Traumatic Brain Injury Phase 2 Clinical Trial Insights

6. Traumatic Brain Injury Phase 1 Clinical Trial Insights

7. Traumatic Brain Injury Preclinical Research Insights

8. Traumatic Brain Injury Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/4mmksk/traumatic_brain

View source version on businesswire.com: http://www.businesswire.com/news/home/20171127005419/en/

Business Wire
www.businesswire.com

Last updated on: 27/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.